Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: PLURI BIOTECH LTD
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-01 to 2024-06-30
Current total value of award: $1445145
Description: DEVELOPMENT OF PLX-R18 CELL THERAPY AS A COUNTERMEASURE FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME